Carlo Marchetti
Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
NLR Family, Pyrin Domain-Containing 3 Protein | 15 | 2023 | 152 | 4.100 |
Why?
| Inflammasomes | 14 | 2023 | 123 | 3.880 |
Why?
| Anti-Inflammatory Agents | 5 | 2020 | 469 | 2.080 |
Why?
| Myocardial Reperfusion Injury | 7 | 2017 | 107 | 1.670 |
Why?
| Nitriles | 4 | 2021 | 158 | 1.460 |
Why?
| Carrier Proteins | 7 | 2016 | 740 | 1.430 |
Why?
| Myeloid-Derived Suppressor Cells | 2 | 2021 | 58 | 0.930 |
Why?
| Inflammation | 7 | 2023 | 2598 | 0.910 |
Why?
| Myocardial Ischemia | 4 | 2016 | 267 | 0.800 |
Why?
| Interleukin-1beta | 7 | 2021 | 383 | 0.790 |
Why?
| Macrophages | 3 | 2018 | 1334 | 0.770 |
Why?
| Melanoma, Experimental | 2 | 2021 | 116 | 0.760 |
Why?
| Interleukin-1 | 5 | 2023 | 987 | 0.680 |
Why?
| Arthritis, Reactive | 1 | 2018 | 8 | 0.670 |
Why?
| Arthritis, Gouty | 1 | 2018 | 14 | 0.660 |
Why?
| Neoplasm Proteins | 1 | 2021 | 415 | 0.620 |
Why?
| Arthritis, Experimental | 1 | 2018 | 130 | 0.580 |
Why?
| Inflammation Mediators | 1 | 2019 | 515 | 0.560 |
Why?
| Inflammatory Bowel Diseases | 2 | 2022 | 290 | 0.540 |
Why?
| Dimethyl Sulfoxide | 1 | 2015 | 45 | 0.520 |
Why?
| Animals | 30 | 2023 | 34133 | 0.460 |
Why?
| Myocardial Infarction | 6 | 2017 | 1134 | 0.460 |
Why?
| Benzamides | 1 | 2014 | 175 | 0.460 |
Why?
| Mice | 21 | 2023 | 15888 | 0.430 |
Why?
| Cardiovascular Agents | 4 | 2017 | 140 | 0.430 |
Why?
| Caspase 1 | 6 | 2018 | 143 | 0.400 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 302 | 0.400 |
Why?
| Sulfonamides | 1 | 2014 | 455 | 0.380 |
Why?
| Interleukin-18 | 3 | 2018 | 229 | 0.360 |
Why?
| Neoplasms | 1 | 2023 | 2235 | 0.350 |
Why?
| Sepsis | 1 | 2015 | 546 | 0.330 |
Why?
| Ventricular Function, Left | 6 | 2017 | 493 | 0.310 |
Why?
| Peritonitis | 2 | 2019 | 78 | 0.290 |
Why?
| Myocardial Reperfusion | 2 | 2017 | 62 | 0.290 |
Why?
| Mice, Inbred C57BL | 8 | 2022 | 5020 | 0.280 |
Why?
| alpha 1-Antitrypsin | 2 | 2017 | 123 | 0.270 |
Why?
| Ventricular Dysfunction, Left | 4 | 2015 | 401 | 0.240 |
Why?
| Myocardium | 3 | 2017 | 982 | 0.230 |
Why?
| Signal Transduction | 7 | 2021 | 4902 | 0.220 |
Why?
| Receptors, Interleukin-1 Type I | 2 | 2020 | 22 | 0.220 |
Why?
| Mice, Knockout | 5 | 2021 | 2737 | 0.220 |
Why?
| Wnt Signaling Pathway | 1 | 2023 | 153 | 0.210 |
Why?
| Cardiomyopathies | 2 | 2015 | 308 | 0.200 |
Why?
| Interleukin-6 | 3 | 2021 | 702 | 0.200 |
Why?
| Reactive Oxygen Species | 1 | 2023 | 592 | 0.190 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 2 | 2019 | 256 | 0.190 |
Why?
| Molecular Targeted Therapy | 2 | 2020 | 361 | 0.180 |
Why?
| Cytokines | 3 | 2022 | 1928 | 0.180 |
Why?
| STAT3 Transcription Factor | 1 | 2021 | 193 | 0.180 |
Why?
| Colitis | 1 | 2022 | 227 | 0.180 |
Why?
| Immunity, Innate | 2 | 2016 | 762 | 0.170 |
Why?
| Lipopolysaccharides | 3 | 2018 | 875 | 0.170 |
Why?
| Intestinal Mucosa | 1 | 2023 | 543 | 0.170 |
Why?
| Mice, Inbred ICR | 2 | 2016 | 111 | 0.170 |
Why?
| Drug Design | 1 | 2019 | 163 | 0.170 |
Why?
| Stroke Volume | 3 | 2016 | 553 | 0.160 |
Why?
| Male | 16 | 2020 | 59639 | 0.160 |
Why?
| Disease Models, Animal | 9 | 2020 | 3799 | 0.160 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2021 | 367 | 0.160 |
Why?
| Relaxin | 1 | 2017 | 15 | 0.150 |
Why?
| Cells, Cultured | 4 | 2018 | 4162 | 0.150 |
Why?
| Uric Acid | 1 | 2019 | 354 | 0.140 |
Why?
| Immunoglobulin Fc Fragments | 1 | 2016 | 35 | 0.140 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2017 | 198 | 0.140 |
Why?
| Cognitive Dysfunction | 1 | 2020 | 309 | 0.140 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2021 | 715 | 0.140 |
Why?
| Myocarditis | 1 | 2016 | 95 | 0.130 |
Why?
| Radiation Injuries, Experimental | 1 | 2015 | 24 | 0.130 |
Why?
| Dietary Sucrose | 1 | 2015 | 55 | 0.130 |
Why?
| Angiotensin II | 1 | 2015 | 108 | 0.130 |
Why?
| Alzheimer Disease | 1 | 2020 | 513 | 0.130 |
Why?
| Melanoma | 1 | 2021 | 709 | 0.120 |
Why?
| Ventricular Remodeling | 2 | 2014 | 230 | 0.120 |
Why?
| Doxorubicin | 1 | 2015 | 304 | 0.120 |
Why?
| Hydrogen Sulfide | 1 | 2014 | 46 | 0.120 |
Why?
| Diet, High-Fat | 1 | 2015 | 248 | 0.120 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 294 | 0.120 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2014 | 202 | 0.110 |
Why?
| Humans | 14 | 2021 | 122796 | 0.110 |
Why?
| Repressor Proteins | 1 | 2014 | 384 | 0.100 |
Why?
| Heart Failure | 2 | 2015 | 2114 | 0.100 |
Why?
| Antibodies, Monoclonal | 2 | 2014 | 1306 | 0.090 |
Why?
| Heart Diseases | 1 | 2014 | 358 | 0.090 |
Why?
| Cell Line | 1 | 2014 | 2785 | 0.080 |
Why?
| Cardiovascular Diseases | 1 | 2020 | 1859 | 0.080 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2023 | 373 | 0.080 |
Why?
| MicroRNAs | 1 | 2014 | 661 | 0.080 |
Why?
| Tissue Survival | 2 | 2017 | 13 | 0.080 |
Why?
| Time Factors | 4 | 2017 | 6682 | 0.060 |
Why?
| Blood Glucose | 1 | 2014 | 1957 | 0.060 |
Why?
| Systole | 2 | 2015 | 178 | 0.060 |
Why?
| Organoids | 1 | 2023 | 81 | 0.060 |
Why?
| Caspase 3 | 2 | 2014 | 246 | 0.060 |
Why?
| Mice, Transgenic | 2 | 2020 | 2079 | 0.050 |
Why?
| Myocardial Contraction | 2 | 2014 | 339 | 0.050 |
Why?
| Dextran Sulfate | 1 | 2022 | 71 | 0.050 |
Why?
| Interleukins | 1 | 2023 | 246 | 0.050 |
Why?
| Models, Immunological | 1 | 2021 | 100 | 0.050 |
Why?
| Behavior Observation Techniques | 1 | 2020 | 10 | 0.050 |
Why?
| RNA, Messenger | 2 | 2022 | 2720 | 0.050 |
Why?
| Spatial Memory | 1 | 2020 | 17 | 0.050 |
Why?
| Presenilin-1 | 1 | 2020 | 29 | 0.050 |
Why?
| Amyloid beta-Protein Precursor | 1 | 2020 | 56 | 0.050 |
Why?
| Gene Deletion | 1 | 2022 | 365 | 0.050 |
Why?
| Tumor Burden | 1 | 2021 | 277 | 0.050 |
Why?
| Apoptosis | 3 | 2014 | 2532 | 0.050 |
Why?
| Homeostasis | 1 | 2023 | 596 | 0.050 |
Why?
| Immune Tolerance | 1 | 2021 | 355 | 0.040 |
Why?
| Myocytes, Cardiac | 2 | 2014 | 483 | 0.040 |
Why?
| Stem Cells | 1 | 2023 | 576 | 0.040 |
Why?
| Microglia | 1 | 2020 | 214 | 0.040 |
Why?
| Neuronal Plasticity | 1 | 2020 | 224 | 0.040 |
Why?
| Pyrimidines | 1 | 2021 | 388 | 0.040 |
Why?
| Pyrazoles | 1 | 2021 | 366 | 0.040 |
Why?
| Leukocytes | 1 | 2019 | 295 | 0.040 |
Why?
| Administration, Oral | 1 | 2020 | 786 | 0.040 |
Why?
| Weight Loss | 1 | 2022 | 663 | 0.040 |
Why?
| Behavior, Animal | 1 | 2020 | 486 | 0.040 |
Why?
| Cytoprotection | 1 | 2017 | 58 | 0.040 |
Why?
| Cerebral Cortex | 1 | 2020 | 430 | 0.040 |
Why?
| Nitrites | 1 | 2017 | 81 | 0.040 |
Why?
| Troponin I | 1 | 2017 | 83 | 0.040 |
Why?
| Leukocyte Elastase | 1 | 2016 | 84 | 0.030 |
Why?
| Infusions, Subcutaneous | 1 | 2015 | 19 | 0.030 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2017 | 207 | 0.030 |
Why?
| Caspase 7 | 1 | 2014 | 23 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2015 | 131 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2017 | 757 | 0.030 |
Why?
| Candida | 1 | 2014 | 36 | 0.030 |
Why?
| Inhibitory Concentration 50 | 1 | 2014 | 82 | 0.030 |
Why?
| Interleukin-1alpha | 1 | 2014 | 57 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2021 | 2904 | 0.030 |
Why?
| Isoproterenol | 1 | 2014 | 127 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 346 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2017 | 1318 | 0.030 |
Why?
| Sulfides | 1 | 2014 | 102 | 0.030 |
Why?
| Receptors, Adrenergic, beta | 1 | 2014 | 146 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2016 | 661 | 0.030 |
Why?
| Histone Deacetylases | 1 | 2014 | 202 | 0.030 |
Why?
| Fibrosis | 1 | 2015 | 497 | 0.030 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2012 | 112 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2014 | 514 | 0.030 |
Why?
| Monocytes | 1 | 2014 | 523 | 0.030 |
Why?
| Antibodies | 1 | 2014 | 400 | 0.030 |
Why?
| Echocardiography | 1 | 2014 | 591 | 0.030 |
Why?
| Up-Regulation | 1 | 2014 | 891 | 0.020 |
Why?
| Hemodynamics | 1 | 2015 | 1036 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 1181 | 0.020 |
Why?
| Biomarkers | 1 | 2019 | 3662 | 0.020 |
Why?
| Rats | 1 | 2017 | 5426 | 0.020 |
Why?
| Blood Pressure | 1 | 2015 | 1713 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2014 | 2784 | 0.020 |
Why?
| Female | 3 | 2016 | 63629 | 0.020 |
Why?
|
|
Marchetti's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|